Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation.

Immunity | Mar 26, 2000

http://www.ncbi.nlm.nih.gov/pubmed/10755617

The adapter protein RIP plays a crucial role in NF-kappaB activation by TNF. Here we show that triggering of the p55 TNF receptor induces binding of RIP to NEMO (IKKgamma), a component of the I-kappa-B-kinase (IKK) "signalosome" complex, as well as recruitment of RIP to the receptor together with the three major signalosome components, NEMO, IKK1 and IKK2, and some kind of covalent modification of the recruited RIP molecules. It also induces binding of NEMO to the signaling inhibitor A20, and recruitment of A20 to the receptor. Enforced expression of NEMO in cells revealed that NEMO can both promote and block NF-kappaB activation and dramatically augments the phosphorylation of c-Jun. The findings suggest that the signaling activities of the IKK signalosome are regulated through binding of NEMO to RIP and A20 within the p55 TNF receptor complex.

Pubmed ID: 10755617 RIS Download

Mesh terms: Antigens, CD | Cell Line, Transformed | DNA-Binding Proteins | HeLa Cells | Humans | I-kappa B Kinase | Intracellular Signaling Peptides and Proteins | NF-kappa B | Nuclear Proteins | Phosphorylation | Protein-Serine-Threonine Kinases | Proteins | Proto-Oncogene Proteins c-jun | Receptor-Interacting Protein Serine-Threonine Kinases | Receptors, Tumor Necrosis Factor | Receptors, Tumor Necrosis Factor, Type I | Signal Transduction | Tumor Necrosis Factor-alpha

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.